Transfusion-related acute lung injury (TRALI) is a noncardiogenic pulmonary edema that occurs during or within 6 hours after transfusion. Risk factors for TRALI, which is relatively common in critically ill patients, include recent surgery, hematologic malignancy, and sepsis. Here, we report a case of TRALI induced by anti-human leukocyte antigen (anti-HLA) class II antibodies (HLA-DR) occurring after transfusion of platelet concentrates in a patient with acute leukemia. Although most patients with TRALI show improvement within 48?96 hours, our patient's condition rapidly worsened, and he did not respond to supportive treatment. TRALI is a relatively common and serious adverse transfusion reaction that requires prompt diagnosis and management. © 2012 Korean Society of Hematology.
CITATION STYLE
Jin, S. M., Jang, M. J., Huh, J. Y., Park, M. H., Song, E. Y., & Oh, D. (2012). A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia. Korean Journal of Hematology, 47(4), 302–306. https://doi.org/10.5045/kjh.2012.47.4.302
Mendeley helps you to discover research relevant for your work.